| 2024-05-16 | Sale | Day One Biopharmaceuticals, Inc. DAWN | GENERAL COUNSEL | 3,253 0.0037% | $16.08 | $52,304 | -16.79% | |
| 2024-02-16 | Sale | Day One Biopharmaceuticals, Inc. DAWN | GENERAL COUNSEL | 3,242 0.0037% | $15.25 | $49,434 | -2.9% | |
| 2023-11-16 | Sale | Day One Biopharmaceuticals, Inc. DAWN | General Counsel | 5,313 0.0061% | $11.69 | $62,109 | +24.31% | |
| 2021-07-30 | Sale | Bristol-Myers Squibb Company BMY | SVP,ChiefCompliance&EthicsOff. | 4,932 0.0002% | $67.90 | $334,883 | +0.22% | |
| 2021-05-05 | Sale | Bristol-Myers Squibb Company BMY | SVP,ChiefCompliance&EthicsOff. | 6,238 0.0003% | $64.21 | $400,542 | +2.78% | |
| 2020-11-24 | Sale | Bristol-Myers Squibb Company BMY | SVP,ChiefCompliance&EthicsOff. | 1,800 <0.0001% | $63.39 | $114,102 | +0.57% | |
| 2020-05-22 | Sale | Bristol-Myers Squibb Company BMY | SVP,ChiefCompliance&EthicsOff. | 6,400 0.0003% | $61.01 | $390,464 | +2.67% | |
| 2019-12-05 | Sale | Bristol-Myers Squibb Company BMY | Chief Compliance & Ethics Offi | 3,480 0.0002% | $58.81 | $204,659 | +4.21% |